Intramuscular triamcinolone: a safe, effective and underutilized dermatologic therapy.

J Drugs Dermatol

North Florida Dermatology Associates, Jacksonville, FL 32207, USA.

Published: June 2009

Although intramuscular triamcinolone acetonide has been available as a dermatologic therapy for many years, it is used sparingly or not at all by many dermatologists because of concern about its safety, as well as a lack of understanding of its specific therapeutic benefits. This case report discusses the efficacy and safety of intramuscular triamcinolone acetonide, along with description of the specific technique employed by the author, as well as the clinical indications and side effects seen by the author in his practice over time. The report describes the positive results attained in the treatment of many chronic, recalcitrant dermatologic conditions that cannot be adequately controlled by topical therapy alone. Because of its strong safety profile and unique therapeutic efficacy, intramuscular triamcinolone should be considered as a primary therapy for many chronic, steroid responsive, dermatologic conditions requiring a systemic approach.

Download full-text PDF

Source

Publication Analysis

Top Keywords

intramuscular triamcinolone
16
dermatologic therapy
8
triamcinolone acetonide
8
dermatologic conditions
8
intramuscular
4
triamcinolone safe
4
safe effective
4
effective underutilized
4
dermatologic
4
underutilized dermatologic
4

Similar Publications

Objectives: Rotator cuff tendinitis (RCT) is a tendon inflammation often following subacromial impingement syndrome. One of the non-surgical management modalities for RCT is subacromial injection of corticosteroids. Some studies have claimed a correlation between ACTH (Adrenocorticotropic Hormone) deficiency and rotator cuff lesions; hence, intramuscular ACTH analogue injection has been recommended as an option.

View Article and Find Full Text PDF

Rationale: Corticosteroid-responsive type 2 (T2) inflammation underlies the T2-high asthma endotype. However, we hypothesized that type 1 (T1) inflammation, possibly related to viral infection, may also influence corticosteroid response.

Objectives: To determine the frequency and within-patient variability of T1-high, T2-high, and T1/T2-high asthma endotypes and whether virally influenced T1-high disease influences corticosteroid response in asthma.

View Article and Find Full Text PDF

Immune checkpoint inhibitors have revolutionised the treatment of cancer. While very effective, they commonly cause a wide spectrum of immune-related adverse events. These immune-related adverse events can be fatal and often have significant effects on quality of life.

View Article and Find Full Text PDF

Background Isolated nail lichen planus (NLP) without mucocutaneous involvement is rare. Literature about the clinical profile and management is scarce. Aims/Objective We attempted to characterize the clinico-demographic profile and analyze the management outcome of patients with isolated nail lichen planus.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!